Works matching AU Ailawadhi, Sikander

Results: 149
    1
    2
    3
    4
    5

    Measurement error and bias in real-world oncology endpoints when constructing external control arms.

    Published in:
    Frontiers in Drug Safety & Regulation, 2024, p. 1, doi. 10.3389/fdsfr.2024.1423493
    By:
    • Ackerman, Benjamin;
    • Gan, Ryan W.;
    • Meyer, Craig S.;
    • Wang, Jocelyn R.;
    • Zhang, Youyi;
    • Hayden, Jennifer;
    • Mahoney, Grace;
    • Lund, Jennifer L.;
    • Weberpals, Janick;
    • Schneeweiss, Sebastian;
    • Roose, James;
    • Siddique, Juned;
    • Nadeem, Omar;
    • Giri, Smith;
    • Stürmer, Til;
    • Ailawadhi, Sikander;
    • Batavia, Ashita S.;
    • Sarsour, Khaled
    Publication type:
    Article
    6

    Measurement error and bias in real-world oncology endpoints when constructing external control arms.

    Published in:
    Frontiers in Drug Safety & Regulation, 2024, p. 1, doi. 10.3389/fdsfr.2024.1423493
    By:
    • Ackerman, Benjamin;
    • Gan, Ryan W.;
    • Meyer, Craig S.;
    • Wang, Jocelyn R.;
    • Youyi Zhang;
    • Hayden, Jennifer;
    • Mahoney, Grace;
    • Lund, Jennifer L.;
    • Weberpals, Janick;
    • Schneeweiss, Sebastian;
    • Roose, James;
    • Siddique, Juned;
    • Nadeem, Omar;
    • Giri, Smith;
    • Stürmer, Til;
    • Ailawadhi, Sikander;
    • Batavia, Ashita S.;
    • Sarsour, Khaled
    Publication type:
    Article
    7
    8
    9
    10

    The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31430-0
    By:
    • Vo, Josh N.;
    • Wu, Yi-Mi;
    • Mishler, Jeanmarie;
    • Hall, Sarah;
    • Mannan, Rahul;
    • Wang, Lisha;
    • Ning, Yu;
    • Zhou, Jin;
    • Hopkins, Alexander C.;
    • Estill, James C.;
    • Chan, Wallace K. B.;
    • Yesil, Jennifer;
    • Cao, Xuhong;
    • Rao, Arvind;
    • Tsodikov, Alexander;
    • Talpaz, Moshe;
    • Cole, Craig E.;
    • Ye, Jing C.;
    • Multiple Myeloma Research Consortium;
    • Ailawadhi, Sikander
    Publication type:
    Article
    11
    12

    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.

    Published in:
    2018
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Sharma, Mayank;
    • Menghani, Richa;
    • Temkit, M'hamed;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Paulus, Aneel;
    • Aslam, Nabeel;
    • Sher, Taimur;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher;
    • Temkit, M'hamed;
    • Colon-Otero, Gerardo;
    • Chanan-Khan, Asher
    Publication type:
    journal article
    13
    14
    15
    16

    Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 1, p. 95, doi. 10.1111/bjh.18298
    By:
    • Abeykoon, Jithma P.;
    • Vaxman, Julia;
    • Patel, Sanjay V.;
    • Kumar, Shaji;
    • Malave, Gabriella C.;
    • Young, Kimberly S.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy T.;
    • Dispenzieri, Angela;
    • Muchtar, Eli;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Leung, Nelson;
    • Warsame, Rahma;
    • Go, Ronald S.;
    • Bergsagel, Leif;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Gertz, Morie A.;
    • Kapoor, Prashant
    Publication type:
    Article
    17

    Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM Registry.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 1, p. 93, doi. 10.1111/bjh.17131
    By:
    • Abonour, Rafat;
    • Rifkin, Robert M.;
    • Gasparetto, Cristina;
    • Toomey, Kathleen;
    • Durie, Brian G. M.;
    • Hardin, James W.;
    • Terebelo, Howard R.;
    • Jagannath, Sundar;
    • Narang, Mohit;
    • Ailawadhi, Sikander;
    • Omel, James L.;
    • Lee, Hans C.;
    • Srinivasan, Shankar;
    • Kitali, Amani;
    • Agarwal, Amit;
    • Wagner, Lynne
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01310-z
    By:
    • Parrondo, Ricardo D.;
    • Das, Saurav;
    • Sledge, Hanna;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Leung, Nelson;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Elliott, Jamie;
    • Fernandez, Andre;
    • Flott, Caitlin;
    • Chanan-Khan, Asher A.;
    • Roy, Vivek;
    • Ailawadhi, Sikander
    Publication type:
    Article
    27
    28
    29

    Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 5, p. 337, doi. 10.1016/j.clml.2024.12.002
    By:
    • Ramasamy, Karthik;
    • Vij, Ravi;
    • Kuter, David;
    • Cella, David;
    • Durie, Brian G. M.;
    • Abonour, Rafat;
    • Rifkin, Robert M.;
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Cowan, Andrew J.;
    • Ho, Carrie;
    • Dhanasiri, Sujith;
    • Fish, Susan;
    • Yu, Edward;
    • Dhamane, Amol D.;
    • Jiaqi Fang;
    • Marshall, Thomas S.;
    • Samuel, Amir;
    • Liang Liu;
    • Katz, Jessica
    Publication type:
    Article
    30

    Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the Connect® MM Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. 58, doi. 10.1016/j.clml.2024.11.001
    By:
    • Terebelo, Howard R.;
    • Omel, James;
    • Wagner, Lynne I.;
    • Hardin, James W.;
    • Rifkin, Robert M.;
    • Ailawadhi, Sikander;
    • Durie, Brian G. M.;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Gasparetto, Cristina J.;
    • Joshi, Prashant;
    • Yu, Edward;
    • Flick, E. Dawn;
    • Ying-Ming Jou;
    • Lee, Hans C.;
    • Abonour, Rafat;
    • Jagannath, Sundar
    Publication type:
    Article
    31

    The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the Connect® MM Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e336, doi. 10.1016/j.clml.2024.05.021
    By:
    • Abonour, Rafat;
    • Lee, Hans C.;
    • Rifkin, Robert;
    • Ailawadhi, Sikander;
    • Omel, James;
    • Hardin, James W.;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Gasparetto, Cristina;
    • Wagner, Lynne I.;
    • Terebelo, Howard;
    • Mouro, Jorge;
    • Dhanasiri, Sujith;
    • Liu, Liang;
    • Yu, Edward;
    • Jagannath, Sundar
    Publication type:
    Article
    32
    33
    34

    Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 112, doi. 10.1016/j.clml.2022.11.008
    By:
    • Lee, Hans C.;
    • Ramasamy, Karthik;
    • Weisel, Katja;
    • Abonour, Rafat;
    • Hardin, James W.;
    • Rifkin, Robert M.;
    • Ailawadhi, Sikander;
    • Terebelo, Howard R.;
    • Durie, Brian G.M.;
    • Tang, Derek;
    • Joshi, Prashant;
    • Liu, Liang;
    • Jou, Ying-Ming;
    • Che, Min;
    • Hernandez, Gabriela;
    • Narang, Mohit;
    • Toomey, Kathleen;
    • Gasparetto, Cristina;
    • Wagner, Lynne I.;
    • Jagannath, Sundar
    Publication type:
    Article
    35

    Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 3, p. 149, doi. 10.1016/j.clml.2021.08.007
    By:
    • Gasparetto, Cristina;
    • Jagannath, Sundar;
    • Rifkin, Robert M.;
    • Durie, Brian G.M.;
    • Narang, Mohit;
    • Terebelo, Howard R.;
    • Toomey, Kathleen;
    • Hardin, James W.;
    • Wagner, Lynne;
    • Ailawadhi, Sikander;
    • Omel, James L.;
    • Srinivasan, Shankar;
    • Dhalla, Mazaher;
    • Catamero, Donna;
    • Kitali, Amani;
    • Agarwal, Amit;
    • Abonour, Rafat
    Publication type:
    Article
    36

    P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S109, doi. 10.1016/S2152-2650(21)02263-1
    By:
    • Wagner, Lynne;
    • Abonour, Rafat;
    • Ailawadhi, Sikander;
    • Durie, Brian G.M.;
    • Gasparetto, Cristina J.;
    • Hardin, James W.;
    • Lee, Hans;
    • Narang, Mohit;
    • Rifkin, Robert;
    • Terebelo, Howard;
    • Toomey, Kathleen;
    • Joshi, Prashant;
    • Agarwal, Amit;
    • Braverman, Julia;
    • Dhanda, Devender S.;
    • Mia He;
    • Jagannath, Sundar
    Publication type:
    Article
    37

    MM-200: A Qualitative Study of Patients' Preferences for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, and Germany.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S428, doi. 10.1016/S2152-2650(21)01955-8
    By:
    • Thomas, Caitlin;
    • Gelhorn, Heather;
    • Mulnick, Sarah;
    • Popat, Rakesh;
    • Ailawadhi, Sikander;
    • Kleinman, David;
    • McDermott, Eleanor;
    • Gorsh, Boris;
    • Perera, Sue;
    • Eliason, Laurie;
    • Sapra, Sandhya;
    • Sansbury, Leah;
    • O'Neill, Alicia;
    • Paka, Prani;
    • Galinsky, Jayne;
    • Tolley, Julia;
    • Ross, Melissa
    Publication type:
    Article
    38

    IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    39

    Poster: MM-200: A Qualitative Study of Patients' Preferences for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, and Germany.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01598-6
    By:
    • Thomas, Caitlin;
    • Gelhorn, Heather;
    • Mulnick, Sarah;
    • Popat, Rakesh;
    • Ailawadhi, Sikander;
    • Kleinman, David;
    • McDermott, Eleanor;
    • Gorsh, Boris;
    • Perera, Sue;
    • Eliason, Laurie;
    • Sapra, Sandhya;
    • Sansbury, Leah;
    • O'Neill, Alicia;
    • Paka, Prani;
    • Galinsky, Jayne;
    • Tolley, Julia;
    • Ross, Melissa
    Publication type:
    Article
    40

    Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    41

    Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
    By:
    • Abeykoon, Jithma;
    • Zanwar, Saurabh;
    • Ansell, Stephen;
    • Muchtar, Eli;
    • Rong He;
    • Greipp, Patricia;
    • King, Rebecca;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy;
    • Habermann, Thomas;
    • Inwards, David;
    • Go, Ronald;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie;
    • Witzig, Thomas;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    42

    Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
    By:
    • Parrondo, Ricardo D.;
    • Moustafa, Muhamad Alhaj;
    • Reeder, Craig;
    • Sher, Taimur;
    • Roy, Vivek;
    • Muchtar, Eli;
    • Warsame, Rahma;
    • Alegria, Victoria;
    • Gonsalves, Wilson;
    • Dingli, David;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Chanan-Khan, Asher A.;
    • Ailawadhi, Sikander
    Publication type:
    Article
    43

    Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e449, doi. 10.1016/j.clml.2020.12.023
    By:
    • Kumar, Vivek;
    • Ailawadhi, Meghna;
    • Dutta, Navnita;
    • Abdulazeez, Mays;
    • Aggarwal, Chander Shekher;
    • Quintero, Gerson;
    • Baksh, Mizba;
    • Roy, Vivek;
    • Taimur Sher;
    • Alegria, Victoria;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Ailawadhi, Sikander
    Publication type:
    Article
    44
    45
    46
    47

    Effect of t(11;14) on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e74, doi. 10.1016/j.clml.2019.09.118
    By:
    • Gasparetto, Cristina J.;
    • Jagannath, Sundar;
    • Rifkin, Robert;
    • Durie, Brian;
    • Narang, Mohit;
    • Terebelo, Howard;
    • Toomey, Kathleen;
    • Hardin, James;
    • Wagner, Lynne;
    • Ailawadhi, Sikander;
    • Omel, Jim;
    • Lee, Hans;
    • Srinivasan, Shankar;
    • Dhalla, Mazaher;
    • Catamero, Donna;
    • Agarwal, Amit;
    • Abonour, Rafat
    Publication type:
    Article
    48

    Frequency of and Associations Amongst Baseline Cytogenetics in Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e75, doi. 10.1016/j.clml.2019.09.119
    By:
    • Ailawadhi, Sikander;
    • Gasparetto, Cristina J.;
    • Jagannath, Sundar;
    • Rifkin, Robert;
    • Durie, Brian;
    • Narang, Mohit;
    • Terebelo, Howard;
    • Toomey, Kathleen;
    • Hardin, James;
    • Wagner, Lynne;
    • Omel, Jim;
    • Lee, Hans;
    • Srinivasan, Shankar;
    • He, Mia;
    • Dhalla, Mazaher;
    • Catamero, Donna;
    • Bharadwaj, Anjali;
    • Agarwal, Amit;
    • Abonour, Rafat
    Publication type:
    Article
    49
    50